Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series

Nevoid basal-cell carcinoma syndrome (Gorlin syndrome) is characterized by numerous cutaneous basal cell carcinomas mediated by mutations in the hedgehog pathway. Vismodegib or sonidegib represent promising treatment options. We identified 10 Gorlin patients who were treated with sonidegib (n = 6) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wescott, Raquel, Samlowski, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604938/
https://www.ncbi.nlm.nih.gov/pubmed/37887561
http://dx.doi.org/10.3390/curroncol30100661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604938/
https://www.ncbi.nlm.nih.gov/pubmed/37887561
http://dx.doi.org/10.3390/curroncol30100661

Ejemplares similares